FERIOTTO, Giordana
 Distribuzione geografica
Continente #
NA - Nord America 8.182
EU - Europa 2.088
AS - Asia 1.953
SA - Sud America 140
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 12.378
Nazione #
US - Stati Uniti d'America 8.167
CN - Cina 849
SG - Singapore 667
UA - Ucraina 603
DE - Germania 416
IT - Italia 406
TR - Turchia 342
GB - Regno Unito 215
SE - Svezia 173
FI - Finlandia 138
BR - Brasile 129
ID - Indonesia 29
BE - Belgio 25
PL - Polonia 23
FR - Francia 21
IN - India 20
RU - Federazione Russa 18
NL - Olanda 16
CA - Canada 14
IR - Iran 11
HK - Hong Kong 10
RO - Romania 8
LT - Lituania 6
AT - Austria 5
IQ - Iraq 5
AR - Argentina 4
CZ - Repubblica Ceca 4
AU - Australia 3
BD - Bangladesh 3
EC - Ecuador 3
EU - Europa 3
MA - Marocco 3
HR - Croazia 2
KE - Kenya 2
PK - Pakistan 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AI - Anguilla 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
GE - Georgia 1
IE - Irlanda 1
IL - Israele 1
JO - Giordania 1
JP - Giappone 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
SN - Senegal 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 12.378
Città #
Woodbridge 1.052
Fairfield 871
Ashburn 663
Jacksonville 660
Houston 590
Chandler 550
Ann Arbor 457
Santa Clara 395
Seattle 375
Wilmington 354
Singapore 314
Cambridge 289
New York 210
Izmir 204
Nanjing 192
Beijing 179
Princeton 144
Ferrara 138
Boardman 100
San Diego 74
Shenyang 67
Milan 65
Bremen 49
Nanchang 48
Shanghai 45
Tianjin 44
Hebei 39
Addison 37
San Mateo 34
Changsha 33
Los Angeles 32
Jinan 31
Jakarta 29
Jiaxing 27
Mountain View 26
Bologna 25
Brussels 25
Norwalk 23
Warsaw 23
Zhengzhou 22
Falls Church 21
Ningbo 21
Auburn Hills 20
Redwood City 20
Dearborn 19
London 17
Munich 17
Verona 15
Helsinki 14
Falkenstein 13
Kunming 12
Leawood 12
Padova 11
Guangzhou 10
Hangzhou 10
Hong Kong 10
Lanzhou 10
Philadelphia 10
Ardabil 9
Des Moines 9
Indiana 9
Orange 9
Augusta 8
Frankfurt am Main 8
Tappahannock 8
Toronto 8
Nuremberg 7
Council Bluffs 6
Düsseldorf 6
Hefei 6
Redmond 6
São Paulo 6
Haikou 5
San Francisco 5
Amsterdam 4
Belo Horizonte 4
Kilburn 4
Mumbai 4
Ottawa 4
Pietro 4
Turin 4
Washington 4
Andover 3
Brno 3
Fortaleza 3
Fuzhou 3
Goiânia 3
Indore 3
Islington 3
Lappeenranta 3
Modena 3
Monmouth Junction 3
Posina 3
Rome 3
San Jose 3
Treviso 3
Vienna 3
Acton 2
Appiano Gentile 2
Baghdad 2
Totale 8.995
Nome #
[2,1-c][1,4]benzodiazepine (PBD)-distamycin hybrid inhibits DNA binding to transcription factor Sp1 374
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 186
Antiproliferative Activity of Novel Isatinyl/Indanyl Nitrones (INs) as Potential Spin Trapping of Free Radical Intermediates 164
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 155
A Novel Frameshift Mutation (+A) at Codon 18 of the beta-Globin Gene Associated with High Persistence of Fetal Hemoglobin Phenotype and deltabeta-Thalassemia 144
Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues 139
Alteration of the expression of human estrogen receptor gene by distamycin 139
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 139
A chromatographic procedure for fully automated isolation of DNA from human whole blood 135
Polymerase-chain reaction as a tool for investigations on sequence-selectivity of DNA-drugs interactions 134
Capillary electrophoresis: detection of hybridization between synthetic oligonucleotides and HIV-1 genomic DNA amplified by polymerase-chain reaction 132
Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA 130
A non-radioactive automated protocol to study protein-DNA interactions by DNase I footprinting 130
New trends in non-invasive prenatal diagnosis: Applications of dielectrophoresis-based Lab-on-a-chip platforms to the identification and manipulation of rare cells (Review) 129
Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA 128
Analysis of the human HLA-DRA gene upstream region: evidence for a stem-loop array directed by nuclear factors 126
Methylation state of the human HLA-DRA gene in T-lymphocytes and B-lymphocytes of transgenic mice. Lack of methylation at one 5'-GCGC site is not required for gene expression 124
Differential effects of distamycin analogues on amplification of human gene sequences by polymerase-chain reaction 124
Antiproliferative effect and antiproteolytic activity of tetra-behzamidine derivatives 124
Biosensor technology and surface plasmon resonance for real-time detection of HIV-1 genomic sequences amplified by polymerase chain reaction 123
Generation and molecular characterization of a transgenic mouse line carrying a mutated human IVS-I-6 thalassemia beta-globin gene 121
Biosensor technology and surface plasmon resonance for real-time detection of genetically modified Roundup Ready soybean gene sequences 121
The DNA-binding drugs mithramycin and chromomycin are powerful inducers of erythroid differentiation of human K562 cells 120
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 119
Polymerase-chain reaction: analysis of DNA/DNA hybridization by capillary electrophoresis 118
Establishment and characterization of a leukemic murine cell line derived from MCF 247 MuLV‐induced T‐cell lymphoma 118
In vitro and in vive binding of a CC-1065 analogue to human gene sequences: A polymerase-chain reaction study 117
Inhibition of ‘in vitro’tumor cell growth by aromatic polyamidines exhibiting antiproteinase activity 116
Liposomes as carriers for DNA-PNA hybrids 115
Quantitation of Bt-176 maize genomic sequences by surface plasmon resonance-based biospecific interaction analysis of multiplex polymerase chain reaction (PCR) 115
Biospecific interaction analysis (BIA) of low-molecular weight DNA-binding drugs. 114
Peptide nucleic acids and biosensor technology for real-time detection of the cystic fibrosis W1282X mutation by surface plasmon resonance 114
Enhanced recognition of cystic fibrosis W1282X DNA point mutation by chiral peptide nucleic acid probes by a surface plasmon resonance biosensor 113
Distamycin analogues with improved sequence-specific DNA binding activities 112
Real-time multiplex analysis of four beta-thalassemia mutations employing surface plasmon resonance and biosensor technology 110
Tissue-specific expression of the HLA-DRA gene in transgenic mice 110
Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene 110
Surface plasmon resonance for real-time monitoring of molecular interactions between a triple helix forming oligonucleotide and the Sp1 binding sites of human Ha-ras promoter: effects of the DNA-binding drug chromomycin 110
Selective binding to human genomic sequences of two synthetic analogues structurally related to U-71184 and adozelesin 109
Sequence-specific recognition of the HIV-1 long terminal repeat by distamycin: a DNAase I footprinting study 107
TAPP (tetra-p-amidinophenoxyneopentane) inhibits the binding of nuclear factors to target DNA sequences 107
Sequencing of an upstream region of the human HLA-DRA gene containing X' and Y' boxes 107
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 106
Chromatography in DNA radiolabeling: hands-off automation using a robotic workstation 104
Effects of Medicinal Plant Extracts on Molecular Interactions between DNA and Transcription Factors 104
Inhibition of HIV-1 LTR-driven in vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site 102
Modular usage of the HLA-DRA promoter in extra-hematopoietic and hematopoietic cell types of transgenic mice 101
DNA-binding activity on the proteinase inhibitor TAPP 98
Detection of hepatitis C virus by unbalanced polymerase-chain reaction, hybridization to synthetic oligonucleotides and capillary electrophoresis 98
null 98
Antisense PNA and PNA-peptide conjugates for the modulation of the beta-globin gene splicing 97
Liposome mediated delivery of retinoids and aromatic polyamidines: Effects on growth of tumor cell lines 97
Methylation state of the human HLA-DRa gene in transgenic mice 96
Surface plasmon resonance for real-time detection of molecular interactions between chromomycin and target DNA sequences 96
null 94
Molecular cloning, expression, functional characterization, chromosomal localization, and gene structure of junctate, a novel integral calcium binding protein of sarco(endo)plasmic reticulum membrane 94
Development and molecular characterization of transgenic mice for beta-thalassemia 91
null 91
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 91
A new automated method for isolation of genomic DNA from eukaryotic cells. 90
New isoxazole derivatives of retinoids: Synthesis and activity on growth and differentiation of tumor cells 90
Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters 90
Synthesis of isoxazole and isoxazoline derivatives of retinoids: effects on growth and differentiation of tumor cells 89
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 89
Binding of distamycin and chromomycin to human immunodeficiency type 1 virus DNA: a non-radioactive automated footprinting study 88
Structure and methylation state of the human transferrin receptor gene: preliminary analysis on tumor cell lines, primary tumors and some normal tissues 88
null 86
Surface plasmon resonance for detection of genetically modified organisms in the food supply 84
null 84
Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription 84
Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for treatment of beta-thalassemia 84
Increase of the expression of gamma-globin gene in human erytroid cells treated with psoralens 82
Produzione di emoglobina in cellule Eritroidi da pazienti con Beta Talassemia alterando processi biomolecolari in grado di regolare l'espressione dei geni per le globine. 82
DNA binding activity and inhibition of DNA-protein interactions. Differential effects of tetra-p-amidino-phenoxyneopentane and its 2′-bromo derivative 80
Surface plasmon resonance and biosensor technology for real-time molecular diagnosis of beta o 39 thalassemia mutation. 80
P1 promoter transcriptional activity of the human AbetaH-J-J locus, encoding Aspartil-beta-hydroxylase, Junctin and Junctate 80
Effetto di poliamidine aromatiche sull' interazione tra fattori di trascrizione e l' LTR di HIV-1 79
Differentiation of Human Leukemic K562 Cells 79
Binding of nuclear factors to the IFN-γ consensus sequence of the human HLA-DRα gene: effects of IFN-γ on tumor cell lines 78
Use of an automated laboratory workstation for isolation of genomic DNA suitable for PCR and allele-specific hybridization. 78
null 77
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 76
EFFECTS OF AROMATIC POLYAMIDINES ON THE ELECTROPHORETIC MOBILITY OF HIV-1 GENOMIC REGIONS AMPLIFIED BY POLYMERASE-CHAIN REACTION 75
Cellular biosensors for the identification of fetal hemoglobin inducers 75
Thalassemia mouse model for beta-globin gene IVSI-6 mutation 74
Multiple levels of control of the expression of the human AβH-J-J locus encoding aspartyl-β-hydroxylase, junctin, and junctate 73
Hemin uptake by erythroleukemic cells treated with iron chelators: effects on the induced expression of differentiated functions. 73
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus 72
Increase in gamma-globin mRNA content in human erythroid cells treated with angelicin analogs 72
Real-time detection of genetically modified maize Bt-176 genomic sequences by surface plasmon resonance-based biospecific interaction analysis 71
Effects of benzamidine derivatives on Ha-ras-1 mRNA accumulation in a Chinese hamster cell line transformed with the activated human T24 Ha-ras-1 oncogene. 70
Ha-RAS-1 transfected cell: induction to differentiation by natural and synthetic retinoids 70
Differential inhibition of DNA/protein interactions by aromatic amidines with 2, 3 and 4 benzamidine residues 70
Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic dystamycin A for the treatment of beta-thalassemia 70
Myocyte enhancer factor 2 activates promoter sequences of the human AβH-J-J locus, encoding aspartyl-β-hydroxylase, junctin, and junctate 69
Differential effects of benzamidine derivatives on the expression of c-myc and HLA-DRα genes in a human B-lymphoid tumor cell line 69
Use of oligonucleotides and PCR for the detection of human sequences in YAC libraries. 69
Evaluation of polyamines as marker of melanoma cell proliferation and differentiation by an improved high-performance liquid chromatographic method 69
Conformation and surface expression of free HLA-CW1 heavy chains in the absence of β2-microglobulin 68
Tetra benzamidine derivatives inhibit hemoglobin accumulation by Friend cells committed to erythroid differentiation by trypsin. 68
Totale 10.334
Categoria #
all - tutte 64.652
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.900
Totale 67.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020576 0 0 0 0 0 0 0 0 147 291 101 37
2020/20211.585 138 124 46 154 47 154 42 196 38 227 282 137
2021/20221.372 49 130 65 67 86 55 54 81 59 126 169 431
2022/20231.285 156 75 28 152 231 206 60 128 138 3 64 44
2023/20241.015 75 106 32 13 45 230 41 283 10 14 20 146
2024/20251.471 66 53 230 99 291 184 92 163 293 0 0 0
Totale 12.562